Fred Alger Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Fred Alger Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$1.29M	–	509
2019 Q2	$1.29M	Buy	10,000 +5,000	+100%	+$593K	0.01%	320
2019 Q1	$589K	Buy	+5,000	New	+$504K	﹤0.01%	360
2017 Q2	–	Sell	-7,500	Closed	-$646K	–	559
2017 Q1	$646K	Buy	+7,500	New	+$540K	﹤0.01%	346

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fred Alger Management's LKFT Position: Q3 2019 in Review

Fred Alger Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2019, closing a stake of 10,000 shares — an estimated $1.29M sold.

Fred Alger Management first reported a position in LKFT in Q1 2017 and held it in 3 quarters. The position peaked at $1.29M in Q2 2019. 111 funds tracked by Wall St. Rank hold LKFT as of Q3 2019.

Fred Alger Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Fred Alger Management sold 10,000 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2019, an estimated $1.29M.
Fred Alger Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2017 and held it in 3 quarters.
Fred Alger Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.29M in Q2 2019.
111 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2019.

Based on Fred Alger Management's 13F filing for Q3 2019, filed 14 Nov 2019.